METHOD OF MONOTHERAPY OF PYLORIC HELICOBACTERIOSIS

medicine, gastroenterology, therapy. SUBSTANCE: treatment is performed with the preparation derinat as 1.5% solution of deoxyribonucleic acid sodium salt in 0.1% sodium chloride solution. The preparation is administrated by an intramuscular route in a dose 5 ml every other day. Treatment course is 3...

Full description

Saved in:
Bibliographic Details
Main Authors KOL'TSOV P.A, ZADIONCHENKO V.S, ROMASHKINA T.S, SEREBRJAKOV S.N, KAPLINA EH.N
Format Patent
LanguageEnglish
Published 27.07.2002
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:medicine, gastroenterology, therapy. SUBSTANCE: treatment is performed with the preparation derinat as 1.5% solution of deoxyribonucleic acid sodium salt in 0.1% sodium chloride solution. The preparation is administrated by an intramuscular route in a dose 5 ml every other day. Treatment course is 3-5 injections. Method ensures to carry out the sanation of stomach mucosa from Helicobacter pylori. Invention is designated for monotherapy of pyloric helicobacteriosis. EFFECT: enhanced effectiveness of therapy of ulcer disease. 4 ex
Bibliography:Application Number: RU19970106393